[go: up one dir, main page]

AR026756A1 - NEW THERAPEUTIC COMBINATIONS (S) -2-BENCILAMINO-METIL) -2,3,8,9-TETRAHIDRO-7H-1,4-DIOXINO [2,3-E] INDOL-8-ONA AND NEUROLETICS FOR THE OPREVENTION TREATMENT OF PSYCHOTIC DISORDERS - Google Patents

NEW THERAPEUTIC COMBINATIONS (S) -2-BENCILAMINO-METIL) -2,3,8,9-TETRAHIDRO-7H-1,4-DIOXINO [2,3-E] INDOL-8-ONA AND NEUROLETICS FOR THE OPREVENTION TREATMENT OF PSYCHOTIC DISORDERS

Info

Publication number
AR026756A1
AR026756A1 ARP000106504A ARP000106504A AR026756A1 AR 026756 A1 AR026756 A1 AR 026756A1 AR P000106504 A ARP000106504 A AR P000106504A AR P000106504 A ARP000106504 A AR P000106504A AR 026756 A1 AR026756 A1 AR 026756A1
Authority
AR
Argentina
Prior art keywords
treatment
psychotic disorders
oprevention
neuroletics
bencilamino
Prior art date
Application number
ARP000106504A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR026756A1 publication Critical patent/AR026756A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Combinaciones terapéuticas utiles en el tratamiento o prevencion de desordenes psicoticos, composiciones farmacéuticas que contienen dichas combinaciones,y su uso en el tratamiento o profilaxis de los desordenes psicoticos.Therapeutic combinations useful in the treatment or prevention of psychotic disorders, pharmaceutical compositions containing such combinations, and their use in the treatment or prophylaxis of psychotic disorders.

ARP000106504A 1999-12-10 2000-12-07 NEW THERAPEUTIC COMBINATIONS (S) -2-BENCILAMINO-METIL) -2,3,8,9-TETRAHIDRO-7H-1,4-DIOXINO [2,3-E] INDOL-8-ONA AND NEUROLETICS FOR THE OPREVENTION TREATMENT OF PSYCHOTIC DISORDERS AR026756A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10

Publications (1)

Publication Number Publication Date
AR026756A1 true AR026756A1 (en) 2003-02-26

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106504A AR026756A1 (en) 1999-12-10 2000-12-07 NEW THERAPEUTIC COMBINATIONS (S) -2-BENCILAMINO-METIL) -2,3,8,9-TETRAHIDRO-7H-1,4-DIOXINO [2,3-E] INDOL-8-ONA AND NEUROLETICS FOR THE OPREVENTION TREATMENT OF PSYCHOTIC DISORDERS

Country Status (20)

Country Link
EP (1) EP1235570A2 (en)
JP (1) JP5557409B2 (en)
KR (1) KR100772854B1 (en)
CN (1) CN1230164C (en)
AR (1) AR026756A1 (en)
AU (1) AU784211B2 (en)
BR (1) BR0016168A (en)
CA (1) CA2396351C (en)
CZ (1) CZ20021880A3 (en)
EA (1) EA005002B1 (en)
HK (1) HK1045942A1 (en)
HU (1) HUP0203309A3 (en)
IL (2) IL149669A0 (en)
MX (1) MXPA02005649A (en)
NO (1) NO20022739L (en)
NZ (1) NZ519381A (en)
PL (1) PL355292A1 (en)
TW (1) TWI222864B (en)
WO (1) WO2001041750A2 (en)
ZA (1) ZA200205484B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415953B8 (en) 2003-10-29 2021-05-25 Wyeth Corp controlled release dosage formulation and set of controlled release dosage forms
TW200640931A (en) 2005-02-17 2006-12-01 Wyeth Corp Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
DK2254598T3 (en) * 2008-02-13 2013-07-29 Targacept Inc COMBINATION OF ALFA 7-NICOTINAGONISTS AND ANTI-CYCOTICS
PT3906927T (en) * 2020-05-04 2022-07-27 Bioprojet Pharma Use of dopamine d3 partial agonists for treating central nervous system disorders
GB202014184D0 (en) 2020-09-09 2020-10-21 Johnson Matthey Plc Modifed catalyst supports and catalysts supported thereon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (en) * 1995-03-16 1999-12-06 大塚製薬 株式会社 Method for producing carbostyril derivative
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
CN1409633A (en) 2003-04-09
EA200200656A1 (en) 2002-12-26
NZ519381A (en) 2004-04-30
IL149669A (en) 2006-06-11
AU1949001A (en) 2001-06-18
NO20022739D0 (en) 2002-06-07
CN1230164C (en) 2005-12-07
TWI222864B (en) 2004-11-01
HK1045942A1 (en) 2002-12-20
EA005002B1 (en) 2004-10-28
KR20030016207A (en) 2003-02-26
KR100772854B1 (en) 2007-11-02
ZA200205484B (en) 2003-12-31
JP5557409B2 (en) 2014-07-23
HUP0203309A3 (en) 2004-12-28
EP1235570A2 (en) 2002-09-04
MXPA02005649A (en) 2004-09-10
IL149669A0 (en) 2002-11-10
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
BR0016168A (en) 2002-08-20
PL355292A1 (en) 2004-04-05
CA2396351A1 (en) 2001-06-14
CZ20021880A3 (en) 2002-08-14
WO2001041750A2 (en) 2001-06-14
WO2001041750A3 (en) 2002-02-14
HUP0203309A2 (en) 2003-01-28
NO20022739L (en) 2002-06-07
JP2003516350A (en) 2003-05-13

Similar Documents

Publication Publication Date Title
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
TR200101481T2 (en) Cancer treatment composition and method using natural herbal essential oils.
CL2003002287A1 (en) COMPOUNDS DERIVED FROM TIENO [3,2-b] -PIRIDINA-6-CARBONITRILOS AND TIENEO [2,3-b] -PIRIDINA-5-CARBONITRILS, PHARMACEUTICAL COMPOSITION, PROCEDURE OF PREPARATION AND INTERMEDIARY COMPOUNDS, AND THEIR USE IN THE TREATMENT OF CANCER, APOPLEJIA, OSTEOPOROSIS
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
AR033548A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A LIPASA INHIBITOR, A PROCEDURE FOR THEIR PREPARATION, TRANSPORTABLE EQUIPMENT IN A KIT MODE, THE USE OF SUCH COMPOSITION IN THE MANUFACTURE OF MEDICINES, A LIPASE INHIBITOR AND A BICYCLE SEQUOSTRANT
ECSP034797A (en) DIHIDRO-BENZO DERIVATIVES [b] [1,4] DIAZEPIN-2-ONA AS ANTAGONISTS II MGLUR2
AR005703A1 (en) SUBSTITUTED OXAZOLIDINONES, PROCEDURE FOR THE PREPARATION, USE OF THE SAME TO PREPARE MEDICINES AND MEDICINES THAT CONTAIN THEM
AR025960A1 (en) SUBSTANCES LIBRARY CONTAINING BICYCLE IMIDAZO-5-IL-AMINES AND / OR BICYCLIC 3-IL-AMINAS IMMEDITION, PROCEDURE FOR THE PREPARATION OF SUBSTANTIAL LIBRARY, AND USE OF SUBSTANCES OF THIS LIBRARY FOR THE PREPARATION OF DRUG PREPARATION
MX9300603A (en) THIACICLIC DERIVATIVES OF PIPERIDINYL.
BR0316296A (en) Lapacone compounds and their methods of use
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
AR012193A1 (en) NEW THERAPEUTIC COMBINATIONS
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
IT1264530B (en) USE OF POLYSACCHARIDES IN ATROPHIC DEGENERATIVE NEUROPATHIES
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
MX9704034A (en) DERIVATIVES AND COMPOSITIONS OF SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-TIADIAZOLIDIN-3-ONA 1,1-DIOXIDE AND METHOD OF USE.
NO983177L (en) Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
AR026756A1 (en) NEW THERAPEUTIC COMBINATIONS (S) -2-BENCILAMINO-METIL) -2,3,8,9-TETRAHIDRO-7H-1,4-DIOXINO [2,3-E] INDOL-8-ONA AND NEUROLETICS FOR THE OPREVENTION TREATMENT OF PSYCHOTIC DISORDERS
SE0001916D0 (en) Novel formulation
UY26498A1 (en) SUBSTITUTED PYRROLES
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2150034T3 (en) USE OF THE 2-AMINOTETRALINS SUBSTITUTED IN 6.7 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SEPTIC SHOCK, AND ANTIPIRETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS.
ES2176642T3 (en) USE OF SULBUTIAMINE FOR THE OBTAINING OF USEFUL PHARMACEUTICAL COMPOSITIONS IN THE TREATMENT OF CERTAIN PSYCHOMOTOR AND PSYCHOINTELECTUAL DISORDERS.

Legal Events

Date Code Title Description
FB Suspension of granting procedure